OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 64 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $7,535,000 | +965.8% | 396,605 | +656.8% | 0.01% | +600.0% |
Q4 2018 | $707,000 | +101.4% | 52,405 | +65.6% | 0.00% | – |
Q3 2018 | $351,000 | -85.2% | 31,640 | -93.5% | 0.00% | -100.0% |
Q4 2016 | $2,372,000 | +136.5% | 483,091 | +138.8% | 0.00% | +100.0% |
Q3 2016 | $1,003,000 | -15.9% | 202,300 | -13.7% | 0.00% | 0.0% |
Q2 2016 | $1,193,000 | +66.4% | 234,307 | +86.5% | 0.00% | +100.0% |
Q1 2016 | $717,000 | -59.8% | 125,641 | -26.8% | 0.00% | -75.0% |
Q4 2015 | $1,782,000 | -1.9% | 171,707 | +74.5% | 0.00% | 0.0% |
Q3 2015 | $1,817,000 | -18.8% | 98,400 | -14.4% | 0.00% | -20.0% |
Q2 2015 | $2,238,000 | +370.2% | 115,020 | +324.4% | 0.01% | +400.0% |
Q1 2015 | $476,000 | -59.0% | 27,100 | -70.6% | 0.00% | -66.7% |
Q3 2014 | $1,161,000 | +91.0% | 92,207 | +137.0% | 0.00% | +200.0% |
Q2 2014 | $608,000 | +234.1% | 38,907 | +114.9% | 0.00% | – |
Q2 2013 | $182,000 | – | 18,107 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|